| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 114346 | Null | 0.00627320055153809 | 0.60676073 |
| NSC 126228 | Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.00627320055153809 | 0.52327782 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.00627320055153809 | 0.42370066 |
| NSC 3077 | s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) | 0.00627320055153809 | 0.24101441 |
| NSC 339137 | PHYSALOLACTONE | 0.00627320055153809 | 0.50787006 |
| NSC 339579 | 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate | 0.00627320055153809 | 0.39813778 |
| NSC 624657 | ANTINEOPLASTIC-624657 | 0.00627320055153809 | 0.29467667 |
| NSC 63878 | Cytarabine Hydrochloride AZ | 0.00627320055153812 | 0.31297069 |
| NSC 642947 | Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- | 0.00627320055153812 | 0.22339883 |
| NSC 644622 | Null | 0.00627320055153812 | 0.4660641 |